CLINICAL_TRIALS
trial_result
· 2014-06-10
Clinical Trial Update: MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial) [Phase 2]
Summary
Phase 2 trial update reporting completion of mesenchymal stromal cell therapy (MyStromalCell) in patients with chronic ischemic heart disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigshospitalet, Denmark | Conditions: Chronic Ischemic Heart Disease | Phase 2 | Status: COMPLETED